Kenneth Research published a report titled “Duloxetine API Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the global duloxetine API market in terms of market segmentation by end-users, application, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
Access full description of the report: https://www.kennethresearch.com/report-details/duloxetine-api-market/10085606
The global duloxetine API market is expected to grow at ~4% CAGR over the forecast period, i.e., 2022-2031. The market is segmented by application into neuropathic pain, generalized anxiety disorder, major depressive disorder, chronic musculoskeletal pain, and others, out of which, the major depressive disorder segment is anticipated to have the highest share with the fastest CAGR during the forecast period. This can be attributed to the rise in the number of patients dealing with depression and an increase in the number of suicides across the globe.
There has been an increase in the use of duloxetine API molecules for the formulation of medicines to provide relief from neuropathic pain to patients. Moreover, there have been growing clinical trials on the API molecules for the development of new medicines. Hence, it is expected to surge the growth of the global duloxetine API market.
Geographically, the global duloxetine API market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Out of them, the market in the Asia Pacific region is estimated to witness noteworthy growth by the end of 2031 owing to the increase in suicidal cases and the rise in spending on the healthcare sector.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Rise in the Number of People Dealing with Depression to Drive the Growth of the Market
According to the World Health Organization, every year more than 700,000 people die due to suicide
There has been a rise in the number of people dealing with depression that can lead to suicide. Furthermore, the increase in the number of suicidal cases is proof of the large number of people dealing with depression. Hence, it is anticipated to drive the growth of the global duloxetine API market.
However, high cost for the manufacturing of medicine and lack of inventory are expected to operate as key restraint to the growth of global duloxetine API market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global duloxetine API market which includes company profiling of Teva Pharmaceutical Industries Ltd., Lupin Limited, Hetero Healthcare Limited, Apotex Inc., SHIONOGI & Co., Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, GPT Pharma, Zhejiang Huahai Pharmaceutical Co., Ltd, Zydus Group, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global duloxetine API market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Get a sample copy of the report: https://www.kennethresearch.com/sample-request-10085606
Kenneth Research is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: [email protected]
U.S. Phone: +1 313 462 0609
0
Sign in to leave a comment.